US FDA issues draft guidance on conducting multiregional clinical trials in oncology: Maryland Wednesday, September 18, 2024, 14:00 Hrs [IST] The US Food and Drug Administration i ...
The Central Drugs Standard Control Organisation (CDSCO) has revised the guidance document for functions and responsibilities of its zonal, sub-zonal and port offices after almost 13 years, updating ...
The National Pharmaceutical Pricing Authority (NPPA) has notified the revised the ceiling price of malaria drug chloroquine phosphate 150 mg, following a direction from the Department of ...
HighField Biopharmaceuticals’ new immuno-oncology drug molecule HF1K16 shows safe and signals efficacy in treating refractory metastatic cancers: Hanghou, China Wednesday, Septe ...
Gates Foundation report calls for targeted global health spending to save millions of children from malnutrition and disease: Seattle Wednesday, September 18, 2024, 11:00 Hrs [IST ...
Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...
Maharashtra FDA cracks down on ayurvedic drug manufacturer for violating DMR Act: Shardul Nautiyal, Mumbai Wednesday, ...
Iran Pharma Expo to be held from October 2 to 4 in Tehran: Shardul Nautiyal, Mumbai Wednesday, September 18, 2024, 08:00 Hrs [IST] The 9th Iran Pharma Expo, scheduled to be he ...
Global healthcare encounters formidable challenges with AMR and sepsis, eyes pathogen sequencing to manage spread: Nandita Vijayasimha, Bengaluru Wednesday, September 18, 2024, 08 ...
PCI member Dr Kumar Ajay designs a roadmap for developing pharmacy education in Bihar: Peethaambaran Kunnathoor, Chennai Wednesday, September 18, 2024, 08:00 Hrs [IST] A roadmap f ...
Civil society organisations opposing the patent applications of US-based pharma major Gilead Sciences for the HIV drug lenacapavir have said that generic competition is needed to make the long acting ...
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) elected a new chair. Tim Leest starts his three-year mandate effective from 16th September. A Belgian national, Tim ...